Friday 6 November 2026 Export NVS’s income statement to Excel — free account

Novartis AG

NVS Healthcare Drug Manufacturers General

Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.

Revenue: +4.67%
EPS: −69.1%
Free cash flow: −17.8%
Total debt: +53.9%

Quarter to September 2026, against a year earlier

162.04 2.94 −1.78%

Follow NVS

Alert me

Market cap: $296.4B
P/E: 30.9×
Fwd P/E: 23.2×
Dividend yield: 2.93%
F-score: 8/9
Altman Z: 4.13
Beneish M: −2.49
Dividend safety: 66/100

Overview

Novartis AG (NVS) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Novartis AG (NVS) trades at a P/S ratio of 5.4×. Over the past ten years it has ranged from 3.0× (September 2022) to 5.8× (February 2026); the current reading is higher than 99% of that period. That is above the Drug Manufacturers General industry median of 3.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/NVS/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Novartis AG P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/NVS/metrics/ps-ratio">Novartis AG (NVS) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	4.7×	24.24%
FY2024	3.8×	(15.55%)
FY2023	4.5×	0.43%
FY2022	4.5×	24.72%
FY2021	3.6×	(13.89%)
FY2020	4.2×	(3.32%)
FY2019	4.3×	3.25%
FY2018	4.2×	8.93%
FY2017	3.8×	13.29%
FY2016	3.4×	(7.97%)

Period	P/S ratio	Change
Sep 2026	4.7×	(10.52%)
Jun 2026	5.3×	2.18%
Mar 2026	5.2×	9.26%
Dec 2025	4.7×	7.66%
43 more quarters	Free account

Against its own ten years

Low 3.0× High 5.8×

Ten-year median 4.0×

Current reading's percentile 99

Company	P/S ratio
PFE Pfizer Inc. compare	2.7×
NVO Novo Nordisk A/S compare	3.5×
AZN AstraZeneca PLC compare	4.7×
NVS Novartis AG	5.4×
MRK Merck & Co., Inc. compare	5.4×
AMGN Amgen Inc. compare	6.4×
JNJ Johnson & Johnson compare	6.6×
GILD Gilead Sciences, Inc. compare	6.7×
ABBV AbbVie Inc. compare	7.7×
Drug Manufacturers General industry median	3.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Novartis AG (NVS) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on NVS

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on NVS

Stockrow Weekly